Skip to main content
Year archive

Gentian Diagnostics ASA — 2020 filings

All 47 regulatory filings released by Gentian Diagnostics ASA (GENT) in 2020, sourced directly from the official regulator.

47 Filings
2020 Period
2020 filings (47)
Filing Released Lang
Share capital increase registered
Share Issue/Capital Change
2020-12-17 English
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference
Investor Presentation
2020-12-15 English
Gentian Diagnostics presents at the DNB Nordic Healthcare Conference
Regulatory Filings
2020-12-15 English
Gentian and research partners with two posters related to the value of calprotectin in management of COVID-19 patients at the AACC
Environmental & Social Information
2020-12-14 English
Gentian and research partners with two posters related to the value of calprotectin in management of COVID-19 patients at the AACC
Regulatory Filings
2020-12-14 English
Gentian and research partners with two posters related to the value of calprotectin in management of COVID-19 patients at the AACC
Report Publication Announcement
2020-12-14 English
Finansiell kalender
Report Publication Announcement
2020-12-09 Norwegian
Financial calendar
Report Publication Announcement
2020-12-09 English
Mandatory notification of trade
Remuneration Information
2020-12-04 English
Share issue in connection with employee share purchase program
Share Issue/Capital Change
2020-12-04 English
New study results confirm the value of calprotectin in management of COVID-19 patients
Regulatory Filings
2020-11-20 English
New study results confirm the value of calprotectin in management of COVID-19 patients
Regulatory Filings
2020-11-20 English
Mandatory notification of trade
Director's Dealing
2020-11-12 English
Gentian Diagnostics divests its subsidiary PreTect AS
M&A Activity
2020-11-05 English
Thrid quarter 2020 financial repor
Earnings Release Q3 2020
2020-10-29 English
Thrid quarter 2020 financial repor
Investor Presentation
2020-10-29 English
Thrid quarter 2020 financial repor
Earnings Release 9M 2020
2020-10-29 English
Presentation of 2020 third quarter results for Gentian Diagnostics AS
Report Publication Announcement
2020-10-22 English
Gentian Diagnostics presents at the Pareto Healtcare conference
Investor Presentation
2020-09-02 English
Gentian Diagnostics presents at the Pareto Healtcare conference
Report Publication Announcement
2020-09-02 English
STUDY CONFIRMS SIGNIFICANTLY ELEVATED LEVELS OF CALPROTECTIN IN PATIENTS WITH SEVERE COVID-19
Regulatory Filings
2020-08-27 English
STUDY CONFIRMS SIGNIFICANTLY ELEVATED LEVELS OF CALPROTECTIN IN PATIENTS WITH SEVERE COVID-19
Regulatory Filings
2020-08-27 English
Primary insider notification - Korr
Director's Dealing
2020-08-27 English
Primary insider notification
Major Shareholding Notification
2020-08-27 English
2nd quarter and first half 2020 report
Interim / Quarterly Report Q2 2020
2020-08-21 English
2nd quarter and first half 2020 report
Investor Presentation
2020-08-21 English
2nd quarter and first half 2020 report
Report Publication Announcement
2020-08-21 English
Presentation of second quarter and first half results for 2020 for Gentian Diagnostics AS
Report Publication Announcement
2020-08-14 English
Gentian awarded up to NOK 8.0 million funding to develop a novel high-throughput COVID-19 antibody test
Regulatory Filings
2020-07-03 English
Release of BÜHLMANN fPELA® turbo
Regulatory Filings
2020-06-16 English
Minutes of Annual General Meeting
AGM Information
2020-05-14 English
Minutes of Annual General Meeting
AGM Information
2020-05-14 English
Notice of Annual General Meeting
AGM Information
2020-04-29 English
Notice of Annual General Meeting
AGM Information
2020-04-29 English
2019 Annual Report
Annual Report FY 2019
2020-04-24 English
2019 Annual Report
Report Publication Announcement
2020-04-24 English
Flaggemelding Gentian Diagnostics AS
Major Shareholding Notification
2020-04-24 Norwegian
Melding vedrørende handel
Major Shareholding Notification
2020-04-24 Norwegian
First quarter 2020 financial report
Investor Presentation
2020-04-24 English
First quarter 2020 financial report
Earnings Release Q1 2020
2020-04-24 English
First quarter 2020 financial report
Earnings Release Q1 2020
2020-04-24 English
Calprotectin, a promising biomarker for prediction of severe events in sepsis
Regulatory Filings
2020-03-27 English
Calprotectin indicates inflammatory response earlier than PCT and CRP
Regulatory Filings
2020-03-27 English
Gentian Diagnostics AS – Primary insider notification
Director's Dealing
2020-03-18 English
4Q 2019 Results and preliminary annual report
Investor Presentation
2020-02-14 English
4Q 2019 Results and preliminary annual report
Interim / Quarterly Report Q4 2019
2020-02-14 English
4Q 2019 Results and preliminary annual report
Report Publication Announcement
2020-02-14 English